Home / HLA-DQA1 Knockout Cell Lines

HLA-DQA1 Knockout Cell Lines

Gene: HLA-DQA1

Official Full Name: major histocompatibility complex, class II, DQ alpha 1provided by HGNC

Gene Summary: HLA-DQA1 belongs to the HLA class II alpha chain paralogues. The class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B Lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa. It is encoded by 5 exons; exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO17098 HLA-DQA1 Knockout cell line (HEK293) Human HLA-DQA1 1:3~1:6 Negative Online Inquiry

Background

HLA-DQA1 gene knockout cell lines are genetically engineered models specifically designed to lack the HLA-DQA1 gene, which plays a crucial role in the immune response by encoding a component of the major histocompatibility complex (MHC) class II molecules. These cell lines serve as invaluable tools for studying antigen presentation and T-cell activation, enabling researchers to dissect the functions of MHC class II in various immune-related contexts. The mechanism underlying their utility involves studying how the absence of HLA-DQA1 affects the interaction between immune cells and antigens, providing insights into immunological disorders and potential therapeutic targets.

The scientific importance of HLA-DQA1 knockout cell lines extends beyond basic research; they are integral in developing and testing novel therapies for autoimmune diseases, allergies, and transplant immunology. In clinical settings, these models can aid in the evaluation of patient-specific responses to therapies, optimizing personalized medicine approaches, and understanding disease mechanisms associated with HLA class II discrepancies.

What distinguishes these cell lines from traditional models is their specificity and reliability in mimicking human immune responses. By eliminating HLA-DQA1, researchers are afforded a unique perspective on MHC class II interactions without confounding factors, allowing for more precise experimental outcomes. Unlike other genetic models, these knockout lines are validated for their functionality and reproducibility in experimental protocols, making them a preferred choice for cutting-edge immunological studies.

For researchers and clinicians, utilizing HLA-DQA1 gene knockout cell lines enhances the potential to unlock new findings in immune regulation and therapeutic advancements. Coupled with our company's extensive expertise in genetic engineering and commitment to quality, we offer these cell lines to empower scientific discovery and innovation in immunology. Our products are carefully designed to meet the rigorous demands of research, ensuring that our clients can rely on them for groundbreaking advancements in their field.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.